Enveloped viruses present several challenges in epidemiology. Their ability to mutate rapidly can lead to the emergence of new strains that may escape vaccine-induced immunity. This necessitates continuous monitoring and updating of vaccines. Moreover, the lipid envelope can complicate vaccine development, as it may obscure or alter viral antigens that are targets for immune responses.
